OASIS and Molecular-replacement Model Completion
Overview
Affiliations
A method of dual-space molecular-replacement model completion has been proposed which involves the programs ARP/wARP, REFMAC, OASIS and DM. OASIS is used in reciprocal space for phase refinement based on models built by ARP/wARP. For this purpose, the direct-method probability formula of breaking SAD/SIR phase ambiguities has been redefined. During the phase refinement, phi(h)('') in the expression phi(h) = phi(h)('') +/- |Delta phi(h)| is redefined as a reference phase calculated from a randomly selected 5% of the atoms in the current structure model, while |Delta phi(h)| is defined as the absolute difference between the phase of the current model and phi(h)(''). The probability formula P(+)(Delta phi(h)) = (1/2) + (1/2) tanh {sin |Delta phi(h)| x [Sigma (h('))m(h('))m(h - h('))kappa(h,h(')) sin(Phi'(3) + Delta phi(h'best) + Delta phi(h - h'best)) + chi sin delta(h)]} is then used to derive the sign of Delta phi(h). In this way the '0-2pi' phase problem is reduced to a 'plus or minus' sign problem. The redefinition implies that during the refinement phases close to the true values will probably be kept unchanged, while those distant from the true values will probably undergo a large shift. This is the desired property of phase refinement. The procedure has been tested using protein diffraction data without SAD/SIR signals. The results show that dual-space MR-model completion making use of OASIS is much more efficient than that without.
Li Z, Fan H, Ding W IUCrJ. 2024; 11(Pt 2):152-167.
PMID: 38214490 PMC: 10916285. DOI: 10.1107/S2052252523010291.
Crystal Structure of Elongation Factor G1.
Gao X, Yu X, Zhu K, Qin B, Wang W, Han P Front Mol Biosci. 2021; 8:667638.
PMID: 34540889 PMC: 8446442. DOI: 10.3389/fmolb.2021.667638.
Ulaganathan T, Shi R, Yao D, Gu R, Garron M, Cherney M Glycobiology. 2016; 27(2):176-187.
PMID: 27621378 PMC: 5224592. DOI: 10.1093/glycob/cww096.
He H, Fang H, Miller M, Phillips Jr G, Su W Acta Crystallogr A Found Adv. 2016; 72(Pt 5):539-47.
PMID: 27580202 PMC: 5006650. DOI: 10.1107/S2053273316010731.
Protein Crystallography from the Perspective of Technology Developments.
Su X, Zhang H, Terwilliger T, Liljas A, Xiao J, Dong Y Crystallogr Rev. 2015; 21(1-2):122-153.
PMID: 25983389 PMC: 4430849. DOI: 10.1080/0889311X.2014.973868.